NewAmsterdam Pharma Company
NAMS
#3717
Rank
โ‚น232.80 B
Marketcap
โ‚น2,175
Share price
0.16%
Change (1 day)
133.77%
Change (1 year)

Revenue for NewAmsterdam Pharma Company (NAMS)

Revenue in 2024 (TTM): โ‚น2.81 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM ) is โ‚น2.86 Billion. In 2023 the company made a revenue of โ‚น1.17 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NewAmsterdam Pharma Company from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น2.81 B139.62%
2023 โ‚น1.17 B